Skip to main content
About
Communities & Collections
All of Brieflands
Statistics
English
العربية
বাংলা
Català
Čeština
Deutsch
Ελληνικά
Español
فارسی
Suomi
Français
Gàidhlig
ગુજરાતી
हिंदी
Magyar
Italiano
Қазақ
Latviešu
മലയാളം
मराठी
Nederlands
ଓଡିଆ
Polski
Português
Português do Brasil
Русский
Srpski (lat)
Српски
Svenska
తెలుగు
தமிழ்
Türkçe
Yкраї́нська
Tiếng Việt
繁体中文
Log In
Log in
New user? Click here to register.
Have you forgotten your password?
Home
Research Center for Gastroenterology and Liver Diseases (BMSU) & Global Hepatitis Network (THC)
Hepatitis Monthly
Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
Loading...
Files
70481-pdf.pdf
(41.11 KB)
Date
2014-11-22
Authors
Mohamad Amin Pourhoseingholi
Sara Ashtari
Seyed Moayed Alavian
Journal Title
Journal ISSN
Volume Title
Publisher
Brieflands
DOI
https://doi.org/10.5812/hepatmon.25540
Abstract
This article does not have abstract.
Description
Keywords
Citation
URI
https://brieflands.com/journals/hepatmon/articles/70481
Collections
Hepatitis Monthly
Endorsement
Review
Supplemented By
Referenced By
Full item page